These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9269500)

  • 1. Development of in vitro-in vivo correlations using various artificial neural network configurations.
    Dowell JA; Hussain AS; Stark P; Devane J; Young D
    Adv Exp Med Biol; 1997; 423():225-39. PubMed ID: 9269500
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial neural network based in vitro-in vivo correlations.
    Hussain AS
    Adv Exp Med Biol; 1997; 423():149-58. PubMed ID: 9269490
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of nonlinear mixed effects modelling in the development of in vitro-in vivo correlations.
    Bigora S; Piscitelli D; Dowell J; Butler J; Farrell C; Devane J; Young D
    Adv Exp Med Biol; 1997; 423():207-15. PubMed ID: 9269497
    [No Abstract]   [Full Text] [Related]  

  • 4. Approaches to IVIVR modelling and statistical analysis.
    Dunne A; O'Hara T; Devane J
    Adv Exp Med Biol; 1997; 423():67-86. PubMed ID: 9269484
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonlinear in vitro-in vivo correlations.
    Mendell-Harary J; Dowell J; Bigora S; Piscitelli D; Butler J; Farrell C; Devane J; Young D
    Adv Exp Med Biol; 1997; 423():199-206. PubMed ID: 9269496
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation of in vitro-in vivo correlation models.
    Young D; Dowell JA; Piscitelli DA; Devane J
    Adv Exp Med Biol; 1997; 423():87-91. PubMed ID: 9269485
    [No Abstract]   [Full Text] [Related]  

  • 7. A general framework for non-parametric subject-specific and population deconvolution methods for in vivo-in vitro correlation.
    Verotta D
    Adv Exp Med Biol; 1997; 423():43-52. PubMed ID: 9269482
    [No Abstract]   [Full Text] [Related]  

  • 8. Examples of developing in vitro-in vivo relationships.
    Butler J
    Adv Exp Med Biol; 1997; 423():93-110. PubMed ID: 9269486
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of skin permeability using an artificial neural network.
    Fu XC; Ma XW; Liang WQ
    Pharmazie; 2002 Sep; 57(9):655-6. PubMed ID: 12369461
    [No Abstract]   [Full Text] [Related]  

  • 10. Issues important to in vitro-in vivo correlation. IVIVR Workshop open discussion.
    Adv Exp Med Biol; 1997; 423():289-95. PubMed ID: 9269504
    [No Abstract]   [Full Text] [Related]  

  • 11. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A renaissance of neural networks in drug discovery.
    Baskin II; Winkler D; Tetko IV
    Expert Opin Drug Discov; 2016 Aug; 11(8):785-95. PubMed ID: 27295548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of in vitro-in vivo correlations (IVIVC) to regulatory agencies.
    Malinowski HJ
    Adv Exp Med Biol; 1997; 423():261-8. PubMed ID: 9269502
    [No Abstract]   [Full Text] [Related]  

  • 14. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution assay development for in vitro-in vivo correlations. Theory and case studies.
    Rohrs BR; Skoug JW; Halstead GW
    Adv Exp Med Biol; 1997; 423():17-30. PubMed ID: 9269480
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro-in vivo correlation strategy applied to an immediate-release solid oral dosage form with a biopharmaceutical classification system IV compound case study.
    Bredael GM; Bowers N; Boulineau F; Hahn D
    J Pharm Sci; 2014 Jul; 103(7):2125-2130. PubMed ID: 24890761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks.
    Ghasemi F; Mehridehnavi A; Pérez-Garrido A; Pérez-Sánchez H
    Drug Discov Today; 2018 Oct; 23(10):1784-1790. PubMed ID: 29936244
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nondestructive quantitative analysis of Paracetamoli powder pharmaceutical by artificial neural network and near-infrared spectroscopy].
    Ren R; Tang Z; Liu F; Gou Y; Ren Y
    Guang Pu Xue Yu Guang Pu Fen Xi; 2001 Aug; 21(4):521-3. PubMed ID: 12945280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Computer simulation of blood level profiles. Drug liberation from two sustained-release preparations and computer simulation of single- and multiple-dose pharmacokinetics].
    Koch HP
    Pharmazie; 1992 Jul; 47(7):547-52. PubMed ID: 1518902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.